Suzanne Eldridge & Francesco Dell'Accio's ReGenerative medicine group researching cartilage biology and innovative #osteoarthritis treatments @EMR_QMUL @QMUL
Meet the impact innovators building ventures at Zinc. Introducing Dr Suzanne Eldridge, co-founder, with Professor Francesco Dell'Accio, of ReFleks https://t.co/Abff4WTMwv
Congratulations to our winners: @DrTinaSmith, @Tap_Track, Sophie Richter and AIKNIT, Suzanne Eldrige and Refleks.
'I loved the human-centred approach to all the innovations…I am leaving more energised than when I came” - Stella Peace
🧵(3/4)
We are recruiting a post doc with strong biochemistry background to generate a new therapeutic for disease modification in osteoarthritis. Please apply here https://t.co/T5K8rpDqwP. Only 24h left.
We are recruiting a post-doc to generate a OA therapeutic suitable for human use. It comes with a generous salary and the project is highly translational. Please apply here https://t.co/T5K8rpDqwP
We are recruiting a PhD student to develop a ROR2 inhibitor suitable for human use.
This studentship (3+1 year) is funded by Versus Arthritis
Interesting candidates will find more information and the application form here: https://t.co/n8QJUTyTu0
🎉Congratulations to our 2023 Award Winners!🎉
Please join us today at 5:30pm at the Opening Ceremony to recognize them. #OARSI2023
Suzanne Eldridge, PhD is the recipient of the Rising Star Award, Basic Science.
We are recruiting a technician on a grant looking in the molecular mechanisms of pain in arthritis!
Advert and application form are found here: https://t.co/I6CHrF7Uiu
Please circulate this to anyone interested
Today Melody Deniz will present her data on technologies for long-lasting ROR2 knockdown within the joint as a therapy for osteoarthritis at the European Society of Gene and Cell Therapy annual congress in Edinburgh #ESGCT22. Check out her poster Poster no.: P692
I would like to congratulate Suzanne Eldridge for her tenure and promotion to Senior Lectured at @QMUL. Well deserved. I am proud for having been her mentor for so many years.
Join our next Arthritis Web Seminar Series Lecture on June 14, at 8am by Dr. Rik Lories, Head of the Div of Rheum @UZLeuven & of @DevReg_KULeuven, who will present on “Molecular identity of the articular chondrocyte to prevent and treat OA” → https://t.co/NP3FddHSYP
PC: 908525
It has been a fantastic #EULAR2022 and we are incredibly happy that our department @EMR_QMUL has had many opportunities to share our science 🧪🧫🧬with you!
👇Here is a photo summary of all our team thorough the various session, from posters, to oral talks to chairing!
Abstract submission deadline for our Cutting Edge OA conference is next Monday, 6th of June! Don't miss out on this exciting line-up of speakers! Register until the 24th of June! https://t.co/NcyMU0Wrmm